Regeneron Pharmaceuticals target price raised to $978 from $660
REGN•UBS raised its target price for Regeneron Pharmaceuticals to $978 from $660.
Related News
Nasdaq halts trading in MF at 10:32 a.m. for volatility
MF•
BlackRock cuts total voting rights in LEG Immobilien to 11.34% from 11.66%
BLK•
Analysts react to CoreWeave debt woes, AI selloff
CRWV•
Westamerica Q3 2026 diluted EPS rises 9% year over year to $1.22
WABC•
Kraft Heinz target price cut to $24 from $27
KHC•